 |
Dr. John Schiller (left) and Dr. Douglas Lowy (right) with HHS Secretary Michael Leavitt
|
Lowy and Schiller Receive Award
Researchers Drs. Douglas Lowy and John Schiller in NCI's CCR recently received the Federal Employee of the Year award from the Partnership for Public Service. At a Washington, DC, gala held in their honor, the Partnership for Public Service presented nine Service to America Medals to outstanding civil servants for their high-impact contributions critical to the safety, health, and well-being of Americans. The top medal went to the NCI scientists for their contributions to the development of the first human papillomavirus vaccine. In accepting the Service to America Medals, the researchers said they hope to continue to try to develop improved and less expensive second-generation versions of the vaccine.
Egorin Receives First Michaele Christian Lectureship
Dr. Merrill Egorin of the University of Pittsburgh Cancer Institute received the first Michaele C. Christian Lectureship. He delivered his lecture, "Pharmacoballistics: Dr. Ehrlich's Magic Bullet in the 21st Century," at the Cancer Therapy Evaluation Program (CTEP) Early Drug Discovery Meeting on September 24. NCI established the lectureship to honor Dr. Christian's 20-year NCI career and to recognize the contributions of individuals to the development of novel agents for cancer therapy. The lecture will be published in Clinical Cancer Research.
If Memory Serves...
Early on, some members of the National Advisory Cancer Council had reservations about placing NCI within the administrative structure of the Public Health Service (PHS); they thought that the Veterans Administration was a better fit. But U.S. Surgeon General Thomas Parran prevailed in his choice of the PHS partly because two cancer-focused research programs already existed within this governance: a group in Boston and another in Washington, DC. (Read more)
For more information about the birth of NCI, go to http://www.cancer.gov/
aboutnci/ncia.
New SEER Monograph Details Cancer Survival among Adults
NCI recently released SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics, which examines cancer survival by patient and tumor characteristics for more than 1.6 million adult cancers diagnosed during 1988-2001. Survival data are from NCI's Surveillance, Epidemiology, and End Results (SEER) Program and represent cancer in approximately one-fourth of the U.S. population. The tumor characteristics may include subsite, size of tumor, extension of the tumor, positive lymph nodes, distant metastases, and histologic type. The patient characteristics are age, race, and sex.
The monograph is available online at http://www.seer.cancer.gov/publications/survival/, where instructions for ordering print copies can be found.
OIA Director Recognized for Middle East Work
Dr. Joe Harford, director of NCI's Office of International Affairs, was recognized recently for his work in the Middle East by the Arab Medical Association Against Cancer (AMAAC). The award was given during the Middle East and North Africa Cancer Research Conference held in Amman, Jordan. Dr. Harford has worked for 10 years in the Middle East serving as NCI liaison to the Middle East Cancer Consortium (MECC), which includes Cyprus, Egypt, Israel, Jordan, Turkey, and the Palestinian Authority. His work with MECC has focused on establishing and strengthening cancer registries as well as individual and group training activities for health care workers and cancer researchers from the region.
|
|
